Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains?Zacks Investment Research • 12/22/25
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion AnnuallyPRNewsWire • 12/11/25
Bet on These 3 Stocks With Upgraded Broker Ratings Amid UncertaintiesZacks Investment Research • 12/08/25
Illumina (ILMN) Moves to Strong Buy: Rationale Behind the UpgradeZacks Investment Research • 12/03/25
Illumina, Inc. (ILMN) Presents at 7th Annual Wolfe Research Healthcare Conference TranscriptSeeking Alpha • 11/19/25
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature studyPRNewsWire • 11/12/25
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanksPRNewsWire • 11/10/25
Compared to Estimates, Illumina (ILMN) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/31/25
Illumina: Innovation Outweighs Short-Term Risks - A Long-Term Buy Ahead Of Q3 EarningsSeeking Alpha • 10/21/25
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insightsPRNewsWire • 10/15/25
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilotPRNewsWire • 10/15/25
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025PRNewsWire • 10/14/25
ILMN Stock Set to Benefit From the Launch of New BioInsight DivisionZacks Investment Research • 10/03/25
Illumina to Join Pharma Partners for CDx Development on KRAS BiomarkerZacks Investment Research • 10/02/25
Illumina launches new business to accelerate technology and data-driven discoveryPRNewsWire • 10/01/25